Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

REGN US Equity

Regeneron Pharmaceuticals, Inc.Health Care · Pharmaceutical Preparations · CIK 872589 · FY ends Dec 31
$840.84
+30.60 (+3.78%)
USD · as of 2026-08-19 · marketstack
9 8-K filings · 0 13D · 2 13G
DateEventWhat happened / filerSource
2026-07-308-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-07-068-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-06-178-K 5.07Submission of matters to a vote of security holderssec.gov ↗
2026-04-3013GSchedule 13G filed — ≥5% beneficial owner (passive) · by VANGUARD CAPITAL MANAGEMENT LLCsec.gov ↗
2026-04-298-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-04-088-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-03-2713G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by VANGUARD GROUP INCsec.gov ↗
2026-01-308-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-01-128-K 7.01Regulation FD disclosuresec.gov ↗
2026-01-128-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2025-10-288-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2025-10-068-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2025-10-06

Every row is a filed document, checked against its EDGAR index.